Macular Edema
Macular Edema - Related Videos
01:18
Pulmonary Edema II: Pathophysiology
0 Views •
2026
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:22
Cerebral Edema ll: Pathophysiology
0 Views •
2026
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:21
Cytotoxic Edema: Pathophysiology
0 Views •
2026
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
01:19
Cerebral Edema l: Introduction
0 Views •
2026
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
03:16
Intravenous Delivery of Receptor Blockers to Reduce Brain Edema in a Mouse Model
0 Views •
2025
Source: Zeynalov, E. et. al., Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema. J. Vis. Exp. (2016)This video demonstrates the intravenous delivery of an arginine-vasopressin (AVP) receptor antagonist in a mouse model. Transient middle cerebral artery occlusion induces brain edema. An AVP receptor antagonist is administered through a catheter in the left jugular vein, alleviating edema.
FAQs
Damage or inflammation affecting retinal blood vessels can weaken the blood-retinal barrier, which normally limits movement of plasma into the retina. Once this barrier becomes less effective, plasma can leak into retinal tissue and contribute to swelling. This vascular change connects the disorder’s microscopic biology with the visual impairment observed clinically.
Fluid accumulation can disrupt the organized structure of light-sensitive cells within the macula. Because this region supports sharp, detailed vision, changes in cellular organization can impair how visual information is processed. The biological outcome is therefore not only increased tissue fluid, but also disturbed retinal architecture in a location essential for visual function.
These conditions are associated with macular edema because retinal vascular damage or inflammatory activity can affect the blood-retinal barrier. Although the associated disorders differ, leakage into retinal tissue represents a shared biological pathway described in the condition. This relationship helps explain why several ocular or systemic disorders can produce similar effects on macular function.
Optical coherence tomography supports diagnosis by allowing clinicians to examine retinal structure in relation to suspected fluid-related swelling. Its value comes from connecting the biological process with an observable retinal finding. In research and clinical assessment, this imaging approach helps guide evaluation of macular changes and supports decisions about how the condition should be managed.
Both anti-VEGF therapy and corticosteroids are included among treatments that reduce vascular leakage. Lowering leakage addresses a central biological process that contributes to fluid accumulation in retinal tissue. Their relevance follows from the condition’s vascular and inflammatory context, although the overview does not specify how these therapies differ mechanistically or when one is selected over the other.
Studying macular edema links vascular-barrier biology, inflammation, retinal cell organization, imaging, and treatment. Researchers can examine how vessel damage changes tissue conditions and how those changes relate to visual function. This subject-specific context also supports the development and evaluation of approaches intended to reduce leakage, while optical coherence tomography provides a way to assess retinal structure.